batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Merus goes into phase 3 12 July 2024 Ipsen makes its second cautious conjugate move 11 July 2024 ADC player Baili to go public in a different guise 11 July 2024 Menarini is late to go early with Orserdu 10 July 2024 Ligand taps Apeiron for a new royalty stream 9 July 2024 Arcus gets anti-CD73 small molecule buy-in 9 July 2024 Gilead mirrors Merck’s endometrial cancer effort 8 July 2024 More Cartitude-4 fears allayed 2 July 2024 Load More